AGP Picks
View all

Middle East News Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.

Press releases published on August 14, 2026

إكس أس دوت كوم تشارك في معرض "ويلث إكسبو" في المكسيك بصفتها الراعي العالمي
Serial Cables Launches PCIe 6.0 CDFP x16 HHHL Host Card with Broadcom Atlas3 Switch
Crypto News: Pepeto Defi Tools Update As the Cardano Price Prediction Reaches for $15
TransFi Launches JARVIS, an AI-Powered Compliance Intelligence Platform for Cross-Border Payments
CentFX Counts Down to Money Expo India 2026, Set to Host Traders at Booth 13 as Platinum Sponsor
Cyabra to Present at Sidoti’s Micro-Cap Virtual Investor Conference on August 19-20
New Crypto: Pepeto Announces $10.65M Raised And Ethereum Price Prediction Targets $15,000 As Market Hunts Its Next Dogecoin
Silexion Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
NOMAD POWER SOLUTIONS FILES 2026 SECOND QUARTER FORM 10-Q, PROVIDES BUSINESS UPDATE
Vistagen Reports Fiscal Year 2027 First Quarter Financial Results and Corporate Update
Quoin Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Clene Reports Second Quarter 2026 Financial Results and Recent Operating Highlights
American Lithium Minerals, Inc. (OTC: AMLM) Reports Fiscal Q3 2026 Results
Maris-Tech Achieves AS9100D Certification, Expanding Access to Global Defense and Aerospace Markets
Nexera: Subsidiary Fort Technology Reports Record First Half of 2026 Results with 49% Revenue Growth to $7.36 Million and 145% Increase in Gross Profit Year over Year and Expanding to Solutions for Data Centers
R3 Life Brings Complete Longevity Lifestyle to Bangkok’s Active Living Community
Replimune Reports Fiscal First Quarter 2027 Financial Results and Provides Corporate Update
BridgeBio Pharma Announces Pricing of Oversubscribed Secondary Offering that Diversifies its Institutional Shareholder Base
Outlook Therapeutics Reports Third Quarter Fiscal Year 2026 Financial Results and Provides Business Update Highlighting FDA Approval of LYTENAVA™
Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update 

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East News Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.